Daniel M. Mulvena

DANIEL M. MULVENA has been Magna-Lab Inc.’s Chairman and CEO since March
1998. Mr. Mulvena has served Boston Scientific Corporation (BSC), a
publicly-traded company which manufactures and sells minimally invasive
medical products, from 1992 to 1995 as Vice President and General
Manager and ultimately as Group Vice President Cardio/Cardiology
responsible for Mansfield, Cardiac Assist and Mansfield
Electrophysiology Divisions of BSC. From 1989 to 1991, Mr. Mulvena was
Chairman, President and CEO of, and from 1991 to 1992 was a consultant
to, Lithox Systems, Inc., a developer and manufacturer of medical
devices. From 1984 to 1989, Mr. Mulvena served as President of Bard
Implants and Bard Cardiosurgery, all divisions of C.R. Bard, Inc. Mr.
Mulvena also serves as Chairman of the Board of EcoCath, Inc., a
publicly-traded medical technology company and serves as a consultant to
and/or on the Board of several privately-held and publicly-held medical
technology companies. He is also the principal owner of Commodore
Associates, a private firm providing consulting services to medical
technology companies.